Sofwave Medical Ltd. (IL:SOFW)
TASE:SOFW
Want to see IL:SOFW full AI Analyst Report?
SOFW Stock Chart & Stats
2800.00
-0.53(-3.47%)
At close: 4:00 PM EST
2800.00
-0.53(-3.47%)
Day’s Range― - ―
52-Week Range1,900.00 - 4,869.00
Previous CloseN/A
Volume25.73K
Average Volume (3M)26.78K
Market Cap
₪1.57B
Enterprise Value560.42M
Total Cash (Recent Filing)₪35.49M
Total Debt (Recent Filing)₪1.44M
Price to Earnings (P/E)69.2
Beta0.52
Next Earnings
Aug 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.22
Shares Outstanding36,132,732
10 Day Avg. Volume28,238
30 Day Avg. Volume26,779
Financial Highlights & Ratios
PEG Ratio-0.22
Price to Book (P/B)9.34
Price to Sales (P/S)3.22
P/FCF Ratio21.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
High Gross MarginsSofwave’s ~75% gross margin reflects strong product-level economics for its ultrasound-based platform and consumables. Durable margins support persistent profitability and cash generation as installed base and per-procedure revenue scale, insulating operating results from cyclical revenue swings.
Strong Free Cash FlowA clear multi-year turnaround to positive operating and free cash flow provides durable funding for R&D, service and distribution expansion. FCF closely tracks net income (free cash flow to net income ~0.95), indicating underlying earnings are translating into real cash available for reinvestment.
Conservative Balance SheetVery low leverage and a small absolute debt load give the company flexibility to fund growth, withstand industry cyclicality, and avoid refinancing risk. This capital structure supports durable strategic choices like targeted R&D, commercial expansion, or opportunistic M&A without immediate liquidity pressure.
Bears Say
Uneven Revenue GrowthRevenue has been inconsistent, with a sharp 2025 slowdown then partial recovery. Durable scaling requires steady end-market adoption and distribution execution; episodic growth raises execution risk, makes forecasting harder, and means profitability could be sensitive to demand shifts or sales cadence.
Cash Conversion VariabilityWhile absolute cash flow is positive, operating cash flow doesn’t consistently cover reported profit, implying working-capital or timing drags. Persistent cash conversion gaps can constrain reinvestment, require working-capital financing, and weaken resilience if revenue growth softens.
Equity Impaired Vs. Prior PeakHistoric losses reduced shareholders' equity below 2021 levels, lowering the capital cushion. Even with low debt today, reduced equity can limit future financing optionality, increase dilution risk if capital raises are needed, and temper investor confidence in long-term resilience.
Sofwave News
SOFW FAQ
What was Sofwave Medical Ltd.’s price range in the past 12 months?
Sofwave Medical Ltd. lowest stock price was 1900.00 and its highest was 4869.00 in the past 12 months.
What is Sofwave Medical Ltd.’s market cap?
Sofwave Medical Ltd.’s market cap is ₪1.57B.
When is Sofwave Medical Ltd.’s upcoming earnings report date?
Sofwave Medical Ltd.’s upcoming earnings report date is Aug 11, 2026 which is in 68 days.
How were Sofwave Medical Ltd.’s earnings last quarter?
Sofwave Medical Ltd. released its earnings results on May 05, 2026. The company reported 10.9 earnings per share for the quarter, beating the consensus estimate of N/A by 10.9.
Is Sofwave Medical Ltd. overvalued?
According to Wall Street analysts Sofwave Medical Ltd.’s price is currently Overvalued.
Does Sofwave Medical Ltd. pay dividends?
Sofwave Medical Ltd. does not currently pay dividends.
What is Sofwave Medical Ltd.’s EPS estimate?
Sofwave Medical Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sofwave Medical Ltd. have?
Sofwave Medical Ltd. has 36,132,732 shares outstanding.
What happened to Sofwave Medical Ltd.’s price movement after its last earnings report?
Sofwave Medical Ltd. reported an EPS of 10.9 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 7.99%.
Which hedge fund is a major shareholder of Sofwave Medical Ltd.?
Currently, no hedge funds are holding shares in IL:SOFW
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sofwave Medical Ltd.
Sofwave Medical Ltd. develops an ultrasound technology for treating fine lines and wrinkles in Israel and internationally. It offers non-invasive skin treatment aesthetic medical devices to physicians. The company was incorporated in 2015 and is based in Yokne'am Illit, Israel.